Radio and PodcastRadio and PodcastLive Radio & Podcasts
Metastatic Breast Cancer — Optimizing the Use of Oral Selective Estrogen Receptor Degraders: Part 2 artwork
Science & Medicine

Metastatic Breast Cancer — Optimizing the Use of Oral Selective Estrogen Receptor Degraders: Part 2

Breast Cancer Update by Dr. Neil Love

Nov 29, 202558:54Science & Medicine

Dr Rinath M Jeselsohn and Dr Joyce O’Shaughnessy review current literature and datasets exploring the use of oral selective estrogen receptor degraders for the management of metastatic breast cancer. CME information and...

Related Episodes

Continue listening to more episodes from Breast Cancer Update.